Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13313904 | 0.93 | TSHR (0.39) | TSHRCA2DGKAADRA2AADRA1A | |
| SCHEMBL2610085 | 0.87 | TSHR (0.39) | TSHRCA2DGKAADRA2AADRA1A | |
| SCHEMBL12050130 | 0.87 | TSHR (0.42) | TSHRCA2DGKAADRA2AADRA1A | |
| SCHEMBL18470077 | 0.87 | TSHR (0.39) | TSHRCA2DGKAADRA2AADRA1A | |
| SCHEMBL28316299 | 0.85 | GAA (0.50) | TSHRALDH1A1GAARAB9ATDP1 | |
| SCHEMBL9275566 | 0.85 | TSHR (0.41) | TSHRCA2DGKAADRA2AADRA1A | |
| SCHEMBL9936851 | 0.85 | CA2 (0.43) | TSHRCA2DGKAADRA2AADRA1A | |
| SCHEMBL12287446 | 0.84 | NAAA (0.48) | TSHRCA2DGKAADRA2AADRA1A | |
| SCHEMBL15108347 | 0.83 | TSHR (0.39) | TSHRDGKAADRA2AADRA1AALDH1A1 | |
| SCHEMBL20862160 | 0.83 | TSHR (0.39) | TSHRCA2DGKAADRA2AADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117897378-A | Plants with increased tolerance to herbicides | 巴斯夫农业种子解决方案美国有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| WO-2023156764-A1 | PROCESS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2023-08-24 | — | — | WO | disclosed |
| CN-115244035-A | Herbicidal phenyluracils | 巴斯夫欧洲公司 | 2022-10-25 | — | — | CN | disclosed |
| EP-3728235-B1 | SUBSTITUTED THIOPHENYLURACILS , THEIR SALTS AND USE OF SAID COMPOUNDS AS HERBICIDAL AGENTS | SYNGENTA CROP PROTECTION AG (CH) | 2022-02-09 | — | — | EP | disclosed |
| EP-3692102-B1 | HIGH WET FAST DISPERSE DYE MIXTURES | DYSTAR COLOURS DISTRIB GMBH (DE) | 2021-11-10 | — | — | EP | disclosed |
| CN-109415289-B | Method for producing 2-methoxyacetic acid | 巴斯夫欧洲公司 | 2021-09-03 | — | — | CN | disclosed |
| US-20210188754-A1 | METHOD FOR PRODUCING 2-METHOXYACETIC ACID | BASF SE (DE) | 2021-06-24 | — | — | US | disclosed |
| US-20210188754-A1 | METHOD FOR PRODUCING 2-METHOXYACETIC ACID | BASF SE (DE) | 2021-06-24 | — | — | US | disclosed |
| EP-3475253-B1 | METHOD FOR PRODUCING 2-METHOXYACETIC ACID | BASF SE (DE) | 2020-09-30 | — | — | EP | disclosed |
| EP-3461861-B1 | HIGH WET FAST DISPERSE DYE MIXTURES | DYSTAR COLOURS DISTRIB GMBH (DE) | 2020-07-15 | — | — | EP | disclosed |
| US-7635696-B2 | Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-12-22 | — | — | US | disclosed |
| US-7635696-B2 | Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-12-22 | — | — | US | disclosed |
| EP-1819713-B1 | ISOXAZOLINE-INDOLE DERIVATIVES WITH AN IMPROVED ANTIPSYCHOTIC AND ANXIOLYTIC A IVITY | JANSSEN PHARMACEUTICA NV (BE) | 2009-09-23 | — | — | EP | disclosed |
| US-7462717-B2 | C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-12-09 | — | — | US | disclosed |
| US-7462717-B2 | C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-12-09 | — | — | US | disclosed |
| US-7416591-B2 | Disperse dye mixtures | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2008-08-26 | — | — | US | disclosed |
| US-20080113988-A1 | Isoxazoline-Indole Derivatives With an Improved Antipsychotic and Anxiolytic Activity | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-05-15 | — | — | US | disclosed |
| US-20080113988-A1 | Isoxazoline-Indole Derivatives With an Improved Antipsychotic and Anxiolytic Activity | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-05-15 | — | — | US | disclosed |
| US-20080022894-A1 | Benzo[1,2-b;4,5-b']difuran-2,6-dione derivatives; anthraquinone and monoazo dyes; black shade; synthetic textile material or fiber blend thereof is a polyester, polyester-cellulose, polyester-nylon, polyesterurethane or polyester-wool blend; ink jet printing | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2008-01-31 | — | — | US | disclosed |
| WO-1982003854-A1 | PROCESS FO ENOLYSIS OF CARBOXYLIC ACID ESTERS | BRADLEY MICHAEL WILLIAM | 1982-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188754-A1 | METHOD FOR PRODUCING 2-METHOXYACETIC ACID | HAO2, PNMT, MT-CO2 | TSHR 3090/4885CA2 44/4885DGKA 626/4885 |
| US-20080113988-A1 | Isoxazoline-Indole Derivatives With an Improved Antipsychotic and Anxiolytic Activity | HTR3A, HTR2C, HTR5A | TSHR 318/4885CA2 2007/4885DGKA 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.